SCHEMBL346189

SCHEMBL346189

[CH2]CCCCCCCCCCCC(C)CCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.40
PRKD3 O94806 1/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCA P17252 1/20 0.33
PRKCH P24723 1/20 0.33
PRKCI P41743 1/20 0.33
PRKCE Q02156 1/20 0.33
PRKCQ Q04759 1/20 0.33
PRKCZ Q05513 1/20 0.33
PRKCD Q05655 1/20 0.33
PRKD1 Q15139 1/20 0.33
OPRM1 P35372 1/20 0.33
SPHK1 Q9NYA1 1/20 0.32
ADH1B P00325 1/20 0.30
ADH1C P00326 1/20 0.30
ADH1A P07327 1/20 0.30
ADH4 P08319 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27038944 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG
SCHEMBL6762035 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG
SCHEMBL5496932 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG
SCHEMBL29125027 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG
SCHEMBL199550 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG
SCHEMBL1041106 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG
SCHEMBL25178024 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG
SCHEMBL5090199 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG
SCHEMBL5090189 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG
SCHEMBL27038946 1.00 ACE2 (0.42) ACE2LMNATSHRPRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1021503-B1 MIXED SURFACTANT SYSTEM PROCTER & GAMBLE (US) 2003-01-29 EP claimed
CN-118201905-A Cationic lipid 武田药品工业株式会社 2024-06-14 CN disclosed
WO-2024018762-A1 PH-SENSITIVE CATIONIC LIPID AND LIPID NANOPARTICLE 国立大学法人北海道大学 2024-01-25 WO disclosed
WO-2024018761-A1 NEUTRAL LIPID AND LIPID NANOPARTICLE 国立大学法人北海道大学 2024-01-25 WO disclosed
WO-2023085299-A1 CATIONIC LIPID 武田薬品工業株式会社 2023-05-19 WO disclosed
EP-2718626-B1 METHOD FOR REDUCING SLAG IN BIOMASS COMBUSTION NALCO CO (US) 2022-06-08 EP disclosed
EP-2448667-B1 ACID GAS SCRUBBING COMPOSITION AND PROCESS NALCO CO (US) 2019-06-26 EP disclosed
EP-2640507-B1 ACID GAS ABSORBENT COMPOSITION NALCO CO (US) 2019-05-08 EP disclosed
EP-2448654-B1 ACID GAS SCRUBBING COMPOSITION NALCO CO (US) 2019-05-01 EP disclosed
US-9920929-B2 Method for reducing slag in biomass combustion ECOLAB USA INC. (US) 2018-03-20 US disclosed
WO-2011006024-A2 METHOD OF REDUCING THE VISCOSITY OF HYDROCARBON FLUIDS NALCO COMPANY (US) 2011-01-13 WO disclosed
US-20110009556-A1 METHOD OF REDUCING THE VISCOSITY OF HYDROCARBON FLUIDS NORRIS RODS, INC., 2011-01-13 US disclosed
WO-2011002767-A2 ACID GAS SCRUBBING COMPOSITION NALCO COMPANY (US) 2011-01-06 WO disclosed
US-20100326276-A1 ACID GAS SCRUBBING COMPOSITION QUARTZDYNE, INC. 2010-12-30 US disclosed
US-20100329953-A1 ACID GAS SCRUBBING COMPOSITION APERGY BMCS ACQUISITION CORP 2010-12-30 US disclosed
EP-1824804-A4 ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS NALCO CO (US) 2009-03-04 EP disclosed
US-20080064611-A1 ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS ECOLAB USA INC. 2008-03-13 US disclosed
EP-1824804-A2 ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS Nalco Company (US) 2007-08-29 EP disclosed
WO-2006052455-A2 ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS NALCO COMPANY (US) 2006-05-18 WO disclosed
US-20060094913-A1 Ion pair amphiphiles as hydrate inhibitors NALCO ENERGY SERVICES 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094913-A1 Ion pair amphiphiles as hydrate inhibitors AQP1, AQP4, AQP3 ACE2 653/4885LMNA 3626/4885TSHR 3972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.